Open Now
Contact Information
9 Nathan D Perlman Place 5th Floor, New York, New York 10003, United States
Detailed Information
Stuyvesant Square CD Treatment Program Inpatient Rehabilitation
-
Services:
- Private non-profit organization
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Maintenance service with medically supervised withdrawal after stabilization
- Buprenorphine maintenance
- Accepts clients using MAT but prescribed elsewhere
- Prescribes naltrexone
- Prescribes buprenorphine
- Adults
- Young Adults
- Mentoring/peer support
- Recovery coach
- Self-help groups
- Assistance with obtaining social services
- Hospital inpatient/24-hour hospital inpatient
- Hospital inpatient treatment
- Substance use treatment
- Family counseling
- Smoking/vaping/tobacco cessation counseling
- Marital/couples counseling
- Group counseling
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Individual counseling
- Substance use disorder education
- Health education services other than HIV/AIDS or hepatitis
- Cash or self-payment
- Private health insurance
- Medicaid
- Medicare
- No formal relationship with prescribing entity
- In-network prescribing entity
- 12-step facilitation
- Substance use disorder counseling
- Brief intervention
- Anger management
- Relapse prevention
- Motivational interviewing
- Cognitive behavioral therapy
- Spanish
- Sign language services for the deaf and hard of hearing
- Adult men
- Adult women
- Clients with co-occurring mental and substance use disorders
- Female
- Male
- Vaping not permitted
- General Hospital (including VA hospital)
- Screening for tobacco use
- Comprehensive substance use assessment
- Complete medical history/physical exam
- Screening for substance use
- Screening for mental disorders
- Comprehensive mental health assessment
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- This facility administers/prescribes medication for alcohol use disorder
- Smoking not permitted
- Nicotine replacement
- Buprenorphine without naloxone
- Clonidine
- Disulfiram
- Medications for HIV treatment
- Buprenorphine with naloxone
- Naltrexone (extended-release, injectable)
- Medication for mental disorders
- Acamprosate (CampralĀ®)
- Naltrexone (oral)
- Lofexidine
- Medications for Hepatitis C treatment
- Buprenorphine (extended-release, injectable)
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- STD testing
- TB screening
- Testing for Hepatitis B (HBV)
- HIV testing
- No formal relationship with prescribing entity
- In-network prescribing entity
- State department of health
- State mental health department
- Drug Enforcement Agency (DEA)
- SAMHSA certification for opioid treatment program (OTP)
- The Joint Commission
- State Substance use treatment agency
- Suicide prevention services
- Domestic violence services, including family or partner
- Social skills development
- Case management service
- Mental health services
Facility Operation (e.g., Private, Public)
Transitional Services
Type of Opioid Treatment
Age Groups Accepted
Recovery Support Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Type of Care
Education and Counseling Services
Payment/Insurance/Funding Accepted
External Opioid Medications Source
Treatment Approaches
Language Services
Special Programs/Groups Offered
Gender Accepted
Facility Vaping Policy
Hospitals
Assessment/Pre-treatment
Opioid Medications used in Treatment
Type of Alcohol Use Disorder Treatment
Facility Smoking Policy
Pharmacotherapies
Testing
External Source of Medications Used for Alcohol Use Disorder Treatment
License/Certification/Accreditation
Ancillary Services
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm